NET PROFIT (x1000 EUR)
EMPLOYEES
Jemo-Pharm A/S
Closing information (x1000 EUR)
| Closing information | 2021/12 | 2020/12 | 2019/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
38
|
-448
|
-978 |
| Total assets |
5,521
|
5,334
|
5,254 |
| Current assets |
3,730
|
3,807
|
3,761 |
| Current liabilities |
4,875
|
4,815
|
5,511 |
| Equity capital |
76
|
54
|
-471 |
| - share capital |
54
|
54
|
679 |
| Employees (average) |
35
|
35
|
35 |
Financial ratios
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Solvency |
1.4%
|
1.0%
|
-9.0% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
76.5%
|
79.1%
|
68.2% |
| Return on equity (ROE) |
50.0%
|
-829.6%
|
207.6% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.